Indiana identifies new gold targets at West Mali

|

Published 03-SEP-2019 13:29 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Indiana Resources Ltd’s (ASX:IDA) review of historic government and termite mound sampling assay data has highlighted a significant untested gold trend on the Koussikoto Licence situated on the eastern side of its West Mali Gold Project.

The new trend at Koussikoto is at least 7.5 kilometres long and defined by historic one kilometre by 250 metre Mali Government sampling, 400 metre by 200 metre infill sampling and historic sampling of termite mounds at approximately 400 metre by 50 metre spacing by previous operators.

Infill sampling is planned by Indiana at 200 metre by 50 metre spacing prior to planning for possible drill testing.

It is important to note that there has been no drill testing of anomalies along this new trend which represents a significant and previously unrecognised target at the West Mali Gold project.

Over 27 kilometres of strike of significant gold anomalism has been identified in the project area to date, across four major trends.

The technical review work recently undertaken was supported by the completion of Indiana’s 2019 exploration activity in Mali.

The review compared recently received drill and soil sampling results with historic data available for the project areas.

The work conducted will now form part of the planning for the upcoming exploration season commencing in October 2019.

Anomalies related to Main Transcurrent Zone

The consistent anomalies identified to date appear related to north–south and northwest-southeast trending structures within or adjacent to the Main Transcurrent Zone (MTZ).

The MTZ is interpreted to be one of the major structures which control mineralisation in Western Mali and Eastern Senegal.

It is considered to be an excellent geological and structural location within the highly prospective Kenieba Inlier of Western Mali, known to host a number of multi-million ounce gold deposits, including the Loulou 12.5 million ounce deposit (Barrick Gold) and the Sabodala 8 million ounce deposit (Teranga Gold).

RC and diamond drilling planned

Management is planning to undertake extensive exploration during the coming field season, acquiring high-resolution satellite photography and elevation data covering the entire West Mali project area.

The company will be conducting detailed geological mapping of high priority targets at Koussikoto, Kenieko Nord and Saboussire.

Soil geochemistry data will be collected at these targets using a 200 metre by 50 metre spacing.

Both reverse circulation and diamond drilling will be undertaken at The Edge to infill the 200 metre long high grade zone and test the extent of mineralisation down plunge to 500 metres below surface as indicated below.

RC and diamond drilling will also be conducted on existing sections at A5 and A7 to confirm orientation of mineralisation followed by step out RC drilling on 40 metre spaced sections north and south.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X